Dr. Michael Southam-Gerow
Associate Chair and Director, Graduate Studies
806 W Franklin, rm 212
Associate Chair and Director of Graduate Studies
Co-Director, Anxiety Clinic
Associate Editor, Journal of Clinical Child & Adolescent Psychology and Journal of Consulting & Clinical Psychology
The Southam-Gerow lab is a busy and exciting place to work and learn. Our focus is the improvement of mental health services for children and families and we are active dissemination and implementation (D&I) researchers. To this end, we have studies that focus in a number of relevant directions. Some of our work involves adapting and testing treatments in community settings through input from stakeholders in the community in an effort to understand how best to adapt treatments for diverse settings. We have several current projects. Two focus on developing instruments designed to measure treatment integrity, one for schools and another for clinics. We plan to continue treatment integrity research with a changing focus on developing and testing ways to measure adherence and competence in the context of ongoing mental health care. We also are engaged in a collaborative project with a large public, community-based mental health agency in the Washington, DC metro area examining patterns of MH care delivery for youth as a pilot toward quality improvement style studies. We are also working with Abbie Kinnebrew and Betsy Farmer from VCU’s School of Social Work on a series of projects related to training and workforce development in social work. Finally, we actively collaborate with researchers from PracticeWise, LLC, including Bruce Chorpita at UCLA, evaluating aspects (e.g., this recent paper) of the Managing and Adapting Practice (MAP) system being used in Los Angeles County and other states around the US.
- CBT for youth anxiety led to strong outcomes for youths, but so did the usual treatments. An important question yet to be answered is why?
Southam-Gerow, M. A., McLeod, B. D., Arnold, C. A., Rodriguez, A., Cox, J. R., Reise, S. P., Bonifay, W. E., Weisz, J. R., & Kendall, P. C. (2016). Initial development of a treatment adherence measure for cognitive-behavioral therapy for child anxiety. Psychological Assessment, 28, 70-80. doi: 10.1037/pas0000141
Hourigan, S. E., Southam-Gerow, M. A., & Quinoy, A. M., (2015). Emotional and behavior problems in an urban pediatric primary care setting. Child Psychiatry and Human Development, 46, 289-299. doi:10.1007/s10578-014-0469-z
Southam-Gerow, M. A., Daleiden, E. L., Chorpita, B. F., Bae, C. Mitchell, C., Faye, M., & Alba, M. (2014). MAPping Los Angeles County: Taking an evidence-informed model of mental health care to scale. Journal of Clinical Child & Adolescent Psychology, 43, 190-200.
Rodriguez, A., Southam-Gerow, M. A., O’Connor, M. K., & Allin, R. B. (2014). An analysis of stakeholder views on children’s mental health services. Journal of Clinical Child & Adolescent Psychology, 43, 862-876.
Southam-Gerow, M. A. & Dorsey, S. (2014). Qualitative and mixed methods research in dissemination and implementation science: Introduction to special series. Journal of Clinical Child & Adolescent Psychology, 43, 845-850.
- Full publication list [PDF]
- Child Therapy, graduate level
- Clinical Practicum, graduate level
- Introduction to Psychology, undergraduate level
Development of a Pragmatic Treatment Integrity Instrument for Child Therapy. Co-Investigator. 2016-2018. National Institute of Mental Health (NIMH). R21-MH109666. Direct costs: $431,244.
Development and Validation of Treatment Integrity Measures for Classroom-Based Interventions. Co-Investigator. 2014-2018. Institute for Educational Sciences (IES), Goal 5. R305A140487. Direct costs: $1,599,923.
Local Quality Assurance Tool for Family Therapy in Usual Care for Adolescent Substance Use. Co-Investigator. February 2015-January 2019. National Institute of Drug Abuse. R01 DA037496. Direct costs: $1,645,806.
Development and Validation of Child Therapy Integrity Measures. Co-Principal Investigator. May 2010-February 2016. National Institute of Mental Health (NIMH). R01MH086529. $1,125,000.